Description
Tracks the presence of minimal residual disease (MRD) in patients undergoing cancer treatment, using next-generation sequencing (NGS) technology.
This lab test includes home sample collection via a provided kit or by a clinician, and you'll receive a comprehensive physical health report with your results.